role in this process [1] . Generally, TGF-␤ induces the itself, but not its receptors. Our study explored the effects of fully human monoclonal antibody against TGF-␤IIR (hTGFdeposition of ECM via stimulation of ECM production ␤IIRAb) on experimental proliferative glomerulonephritis. [2] , down-regulation of ECM-degrading proteases and
Methods. hTGF-␤IIRAb was generated from Xenomice. The up-regulation of protease inhibitors [3] . By these mechaexpression of TGF-␤IIR was studied by immunohistochemistry nisms, TGF-␤ is thought to be involved in the progression in normal and anti-Thy-1 nephritis rats. hTGF-␤IIRAb or conof renal fibrosis. Therefore, inhibition of TGF-␤ is control Ab was injected intraperitoneally at day 0 and day 4 of anti-Thy-1 nephritis, and rats were sacrificed at day 7. Effects sidered to be one of the crucial therapeutic strategies to of hTGF-␤IIRAb were assessed by histological and immunoprevent renal fibrosis. Inhibition of TGF-␤ by neutralizpathological measurements.
ing antibody [4], anti-sense oligonucleotide [5], decorin
Results. The specificity of hTGF-␤IIRAb was confirmed by [6, 7] , and TGF-␤ receptor-IgG Fc chimera [8] sup-ELISA and Western blot analysis. By immunostaining, TGF-␤IIR expression was up-regulated in the proliferative lesions pressed the accumulation of ECM in experimental prolifof anti-Thy-1 nephritis at day 7. In the hTGF-␤IIRAb-treated erative glomerulonephritis induced by anti-Thy-1 antigroup, the extent of mesangial expansion was less than that in body. However, all of these reports showed the effects the control group. By immunohistology, ␣-smooth muscle acof inhibition of TGF-␤ itself, but not TGF-␤ receptors.
tin, fibronectin-EDA, and type I collagen were significantly reTransforming growth factor-␤ regulates cellular produced in the hTGF-␤IIRAb-treated group.
Conclusions. Anti-TGF-␤IIR antibody ameliorated ECM cesses by binding to three high-affinity cell-surface recepaccumulation in anti-Thy-1 nephritis. Our data suggest that tors: types I, II, and III [9] . In the extracellular space, TGF-␤IIR may be one of the therapeutic targets, and that fully TGF-␤ binds either to the type III receptor, which prehuman monoclonal antibody against TGF-␤IIR may have a sents it to the type II receptor (TGF-␤IIR), or directly new therapeutic potential for renal fibrosis.
to TGF-␤IIR on the cell membrane. Then the TGF-␤-TGF-␤IIR complex binds to the type I receptor, and finally, phosphorylation of the type I receptor occurs [10] . Phosphorylation activates several signaling pathways, including the Smad pathway, and regulates multi-therapeutic target to prevent renal fibrosis. Recently, a new strategy for producing fully human [12, 13] . Seven-week-old female Wistar rats were purchased from Chubu Kagaku Shizai Co. Ltd. (Nagoya, Pharmaceutical, Osaka, Japan). After washing with PBS containing 0.1% Tween 20 (Bio-Rad Laboratories, HerJapan) and were allowed free access to food and water. The experiments were performed according to the Anicules, CA, USA; PBS/T), each well was incubated for one hour with 0.0003 to 10 g/mL JMAb-45 in 50 L mal Experimentation Guide of Nagoya University School of Medicine (Nagoya, Japan). PBS/T. Wells were subsequently washed three times with PBS/T and incubated for one hour with 50 L horseradProduction and purification of soluble TGF-␤IIR ish peroxidase labeled anti-human IgG antibody (Amersham Pharmacia Biotech, Buckinghamshire, UK) in PBS/T HEK293 cells were transfected with the plasmid containing the cDNA for the extracellular domain (amino containing 0.5% bovine serum albumin (BSA fraction V; Nacalai Tesque, Kyoto, Japan). After washing four acids 1 to 159) of human TGF-␤IIR. The recombinant soluble TGF-␤IIR was purified by antibody affinity chrotimes with PBS/T, each well was incubated with 100 L tetramethyl bendidine (Bio-Rad Laboratories). The reacmatography using anti-human TGF-␤IIR polyclonal antibody (AF-241-NA; R&D Systems, Minneapolis, MN, tion was terminated by 25 L 0.5 N sulfuric acid, and the absorbance at 450 nm was read on a microplate reader, USA), and then its purity was examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) M-Tmax (Molecular Devices, Sunnyvale, CA, USA). and silver staining. The purified human TGF-␤IIR was Western blot analysis used for immunization.
Soluble TGF-␤IIR (R&D) protein was diluted in equal Generation and characterization of anti-human amounts of 2 ϫ Tris-SDS seprasol buffer (Dai-ichi Chemi-TGF-␤IIR monoclonal antibodies cal, Tokyo, Japan) under an unreduced condition and boiled for five minutes. The protein samples were run Xenomice are characterized by gene targeted-inactivated mouse heavy and chain loci and transgenic for through a 10%/20% gradient acrylamide gel (Dai-ichi Chemical). Different concentrations of sTGF-␤IIR samhuman heavy and chain loci. Thus, these mice are deficient in murine antibody production, but produce ples and molecular-weight standards (7711BTS; New England BioLabs, Beverly, MA, USA) were subjected to human antibodies [12, 13] . Xenomice were immunized once by subcutaneous injection of recombinant soluble electrophoresis for one hour at 40 mA on the vertical transfer membrane (Millipore, Tokyo, Japan). for two hours on a shaker to block nonspecific antibody binding sites. The membrane was washed in Tris-buffered saline (TBS; Takara, Kyoto, Japan) containing 0.1% Tween 20 (TTBS) and incubated with JMAb-45, Table 1 . Tissues for light microscopy were fixed with JMAb-77 or polyclonal goat anti-human TGF-␤IIR antimethacarn overnight, dehydrated through graded ethabody (R&D) for 1.5 hours at room temperature. After nol series and embedded in paraffin. Histologic sections washing with TTBS, the membrane was incubated with of kidneys were stained with periodic acid-Schiff (PAS) anti-human Ig biotinylated sheep whole antibody (Amerand hematoxylin and eosin (HE). A part of the tissues sham Pharmacia Biotech) or anti-goat Ig biotinylated was snap frozen in liquid nitrogen for immunostaining. donkey whole antibody (Amersham Pharmacia Biotech) Immunostaining diluted with TTBS for one hour at room temperature.
Two-micrometer-thick frozen sections were cut by a After washing with TTBS, immobilized antibodies were cryostat, air dried, and fixed in acetone at room temperadetected by luminol reagents (ECL Western blotting ture for 10 minutes. For analysis of glomerular macrophage reagents; Amersham Pharmacia Biotech); subsequently, infiltration, sections were incubated with mAb ED1 (antithe membrane was exposed to ECL hyper-film (Amerrat-macrophage/monocyte, mouse IgG1; BMA), followed sham Pharmacia Biotech) for 30 seconds in the dark to by FITC-labeled goat anti-mouse IgG antibody (Cappel visualize the specific protein bands.
Laboratory, West Chester, PA, USA) as the second reUrinary protein excretion agent. For immunohistological analysis, endogenous peroxiRats were housed in metabolic cages overnight from dase activity was inhibited with 0.1% NaN 3 and 0.3% day 0 to day 1, from day 2 to day 3, and from day 6 to hydrogen peroxide in PBS and nonspecific protein-binding day 7. Urinary protein was measured by a pyrogallol red sites were blocked with normal goat serum. The sections method [14] .
were incubated with mAb 1A4 [anti-␣-smooth muscle actin (␣-SMA) antibody, mouse IgG2a; Dako, Glostrup,
Serum creatinine level
Denmark], IST-9 (anti-cellular fibronectin EDA domain, Serum of each rat was collected at day 3 and at day 7. mouse IgG1; Harlan Sera-lab, Sussex, UK), or rabbit Serum creatinine was measured using the CRE-EN polyclonal anti-collagen I (Chemicon International, TeKainos kit (Kainos, Tokyo, Japan). mecula, CA, USA), followed by a conjugate of polyclonal goat anti-mouse IgG antibodies or goat anti-rabbit
Experimental protocol
IgG antibodies, horseradish peroxidase and dextran backExperimental proliferative glomerulonephritis was inbones (EnVision System; Dako) as the second reagent. duced in female Wistar rats by intravenous injection of To detect the localization of TGF-␤IIR in rat and mouse the monoclonal antibody (mAb) 1-22-3 (mouse IgG3) kidney, endogenous biotin present in the renal tissues [15] . Thirty-nine rats were divided into three groups.
was blocked with avidin/biotin blocking kit in two succesRats of group I (N ϭ 22) and II (N ϭ 22) were injected sive steps (Vector, Burlingame, CA, USA). Then tissues intravenously with 500 g of mAb 1-22-3 in 1.0 mL were incubated with JMAb-45. Immobilized human antisaline as described previously [15] . Group I rats were bodies were detected by biotin-avidin-immunoperoxiintraperitoneally injected with anti-TGF-␤IIR antibody dase technique using Vectastain ABC kit human IgG (JMAb-45, 5 mg/kg) at one hour and four days after mAb (Vector). Finally, the enzyme activity of horseradish per-1-22-3 injection. Rats of group II were intraperitoneally oxidase was detected using 3-amino-9-ethyl-carbazole injected with anti-KLH antibody (JMAb-77, 5 mg/kg) (Dako) or 3,3Ј-diaminobenzidine tetrahydrochloride liqinstead of anti-TGF-␤IIR antibody at the same time uid system (Dako). Negative controls were performed by points. An additional 15 rats were injected intravenously replacement of first step antibodies by isotype-matched with 1.0 mL of saline at day 0 and studied as normal mAb or species-matched antibody. controls (group III). At day 1, six rats of group I, six Morphometric analysis of histology group II, and five group III rats were sacrificed. At day and immunohistology 3, six rats of group I, six group II, and five group III rats were sacrificed. At day 7, the remaining rats were For each kidney and for each type of staining, cross sections of 20 different glomeruli and twenty different sacrificed. The experimental protocol is summarized in tubulointerstitial areas of 0.1 mm 2 were examined as described previously [16] . The total number of nuclei in each glomerulus was counted using tissues stained by PAS. The average number of cells/glomerulus was calculated and used as a representative number. The number of macrophages was counted, and the average numbers per glomerulus were calculated. In each glomerulus, ratio of area positively stained for ␣-SMA, fibronectin-EDA, or type I collagen to total glomerular area was measured by computer-aided planimetry using Mac Scope (Mitani, Fukui, Japan) and expressed as a percentage. Similarly, the ratio of positively stained area in 0.1 mm 2 of tubulointerstitial area was measured [16] .
Statistical analysis
All values are provided as mean Ϯ SD. Statistical analysis was performed by one-way analysis of variance (ANOVA). When significant difference was present, statistical analysis was further performed using the Scheffe F test between two groups. Significant difference was set when the P value was less than 0.05 (5%).
RESULTS

Characterization of fully human anti-TGF-␤IIR monoclonal antibody
ELISA. The direct ELISA for sTGF-␤IIR showed that anti-TGF-␤IIR antibody, JMAb-45, detected sTGF-␤IIR in a dose-dependent manner from 0.01 to 10 g/mL of JMAb-45 concentration (Fig. 1A) . Control antibody (JMAb-77) did not react with sTGF-␤IIR (Fig. 1A) Western blot analysis. Western blotting showed that JMAb-45 specifically detected proteins of 20 to 30 kD. The molecular size of the band reacted with JMAb-45 was similar to that identified by other polyclonal anti-TGF-␤IIR antibody (R&D; Fig. 1B ).
Urinary protein excretion
At day 1 and day 3, the urinary protein of groups I and II was increased when compared with the normal group; however, those were not significantly different 25.8 mg/day, P Ͻ 0.005). The urinary protein excretion of group III was significantly less than that of groups I and II (3.0 Ϯ 1.0 mg/day, P Ͻ 0.005 vs. group I, P Ͻ 0.0001 vs. group II; Fig. 2A ).
group II, 0.45 Ϯ 0.03 mg/dL; group III, 0.45 Ϯ 0.02 mg/ dL). At day 7, the serum creatinine level of group II was Serum creatinine level significantly elevated when compared with that of groups At day 3, the serum creatinine level was not different I or III (group I, 0.65 Ϯ 0.13 mg/dL; group II, 0.78 Ϯ 0.09 mg/dL; group III, 0.60 Ϯ 0.02 mg/dL, P Ͻ 0.005 among the three groups (group I, 0.44 Ϯ 0.02 mg/dL; expression of TGF-␤IIR in normal murine kidney. The expression pattern was similar to that of normal rat kidney (data not shown).
Light microscopic findings
At day 1 and day 3, almost all glomeruli in group I and group II showed mesangiolysis (Fig. 4) . These findings were not different between group I and group II. At day 7, mesangial area of group II was expanded in almost all glomeruli (Fig. 3D) . In several glomeruli, microaneurysm formation, the advanced form of mesangiolysis, was still observed. These pathological findings were comparable to the findings reported previously in antiThy-1 nephritis at day 7 [15] . On the other hand, in group I the extent of mesangial expansion was less than that of group II (Fig. 3C) .
␣-SMA expression and ECM deposition in glomerulus
By immunohistochemistry, ␣-SMA expression was confined to blood vessels, but was not detected in the glomeruli of group III rat (Fig. 3H) . In group II rats, the ␣-SMA-positive area was significantly increased (Fig.  3G) . Expression of ␣-SMA in group I (Fig. 3F) was significantly decreased when compared with group II (Fig. 3G) . Using a computer-aided analyzer, ␣-SMA expression was quantitatively measured. ␣-SMA expression in group I was significantly suppressed when compared to that in group II. Rats of group III did not express ␣-SMA in glomeruli (Fig. 5A) .
Fibronectin-EDA was not detected or weakly positive in the glomerulus from group III rats (Fig. 3K) . In group II, fibronectin-EDA was markedly increased in mesan-
Fig. 2. Urinary protein excretion and serum creatinine levels in (᭺)
gial area and in periglomerular area (Fig. 3J) . In contrast, the glomerular staining of fibronectin-EDA was dramatiAt day 7, urinary protein excretion was significantly increased in group cally decreased in rats of group I (Fig. 3I) lyzer are shown in Figure 5A . ***P Ͻ 0.005 vs. group II; P Ͻ 0.005 vs. group III; ###P Ͻ 0.0001 vs. group III, respectively). (B) At day 3, serum creatinine level among ␣-SMA expression and ECM deposition three groups was not significantly different. At day 7, serum creatinine level of group II was significantly increased compared with group III in interstitium (#P Ͻ 0.05 vs. group III). Serum creatinine level was significantly supIn group III rats, the ␣-SMA expression was confined pressed by injection of JMAb-45 (group I, *P Ͻ 0.05 vs. group II). The difference between group I and group III was statistically not significant. to blood vessel walls. In groups I and II, ␣-SMA was faintly but significantly stained in a part of tubular epithelial cells.
In group III, fibronectin-EDA was weakly positive in group II vs. groups I or III), while those were not signifithe tubulointerstitial area (Fig. 3N) . In group II, exprescantly different between groups I and III (Fig. 2B) .
sion of fibronectin-EDA was increased especially in TGF-␤IIR expression outer medulla (Fig. 3M) . The expression in group I (Fig.  3L ) was significantly less than that of group II. The exIn normal rat kidney, TGF-␤IIR was expressed mainly pression of type I collagen was similar with that of fibroby glomerular epithelial cells and was faintly detected nectin-EDA. Quantitative analysis showed that the difin the apical sites of tubular epithelial cells (Fig. 3A) . In ferences in the fibronectin-EDA and type I collagenanti-Thy-1 nephritis, the expression of TGF-␤IIR was positive area were statistically significant among the up-regulated in glomerulus at day 7, especially by proliferated mesangial cells (Fig. 3B) . We also examined the three groups (Fig. 5B) . Light microscopic findings at day 1 and day 3 are shown by PAS stain (ϫ400). Panel A shows group I at day 1; B, group II at day 1; C, group I at day 3; D, group II at day 3. At day 1 and day 3, almost all glomeruli showed mesangiolysis and cellular infiltration in both groups. These findings were not different between two groups.
Number of total glomerular cells and glomerular cells was significantly increased in groups I glomerular macrophages
and II compared with group III. The number of total glomerular cells in group I was slightly decreased when At day 1 and day 3, the number of total glomerular compared with group II (P Ͻ 0.01; Fig. 6A ). cells was significantly decreased in groups I and II comGlomerular macrophages were rarely detected in pared with group III, but there was no difference between group I and group II. At day 7, the number of total group III. Through all periods of this experiment, the ᭣ Fig. 3 . Light microscopic findings and expression of TGF-␤IIR, ␣-SMA, and fibronectin-EDA at day 7. Immunostaining micrograph shows TGF-␤IIR expression in normal rat kidney (A ϫ400) and anti-Thy-1 nephritis rat kidney at day 7 (B ϫ400). TGF-␤IIR was expressed in glomerulus, especially in glomerular epithelial cells, and faintly in tubular epithelial cells in normal rat kidney (A). TGF-␤IIR expression was increased in both glomerulus and tubules in Thy-1 nephritis at day 7 (B). Light microscopic appearance at day 7 (PAS stain ϫ400 C, D, E: C, group I; D, group II; E, group III). The mesangial area was expanded in group II (D) compared with group III (E). Injection of anti-TGF-␤IIR antibody (group I) suppressed mesangial expansion (C) compared to group II (D). Immunostaining micrograph shows ␣-SMA expression in glomerulus (F, G, H, ϫ200), fibronectin-EDA expression in glomerulus (I, J, K, ϫ200) and in interstitium (L, M, N, ϫ200) (group I is in panels F, I, L; group II, panels G, J, M; group III, panels H, K, N). The expression of ␣-SMA and fibronectin-EDA was not detected or weakly positive in group III (H, K, N) and increased in group II (G, J, M). The expression of both proteins in group I (F, I, L) was significantly reduced when compared to group II. At day 1 and day 3, the reduced in group I when compared with group II (fibronectin-EDA, number of total glomerular cells in group I and II was significantly *P Ͻ 0.0001; type I collagen, **P Ͻ 0.05, respectively).
decreased compared with group III, but there was no difference between group I and group II. At day 7, the number of total glomerular cells in groups I and II was significantly increased compared with group III, and that of group I was reduced compared with group II. The difference between each of the two groups was statistically significant (*P Ͻ 0.0001 number of glomerular macrophages in groups I and II vs. group III; #P Ͻ 0.0001 vs. group III; **P Ͻ 0.0001 vs. group III; ##P Ͻ 0.0001 vs. group III; ***P Ͻ 0.01 vs. group II, P Ͻ 0.0001 vs.
was significantly increased compared with group III. Ingroup III; ###P Ͻ0.0001 vs. group III, respectively). (B) The number filtration of glomerular macrophages in group I was not of glomerular macrophages in groups I and II was significantly increased different at day 1 and day 3, but significantly inhibited compared to group III through all periods. There was no difference between group I and group II at day 1 and day 3, but that of group I at day 7 when compared with group II (Fig. 6B) .
was reduced compared to group II at day 7 (*P Ͻ 0. In addition, the number of total glomerular cells was slightly but significantly decreased natural inhibitor of TGF-␤, decorin [6, 7] ; (3) soluble chimeric TGF-␤ receptor [8] , which competitively block when compared to group II. In general, several investigators reported that, in vitro, TGF-␤ was an inhibitor of the binding of TGF-␤ to its receptors; and (4) TGF-␤ intracellular signaling pathway inhibition by specific inmitogenesis in glomerular cells [26, 27] . In an in vivo situation, however, the effects of TGF-␤ on glomerular hibitor for Rho-associated coiled-coil forming protein kinase (ROCK) (abstract; Nagatoya et al, J Am Soc Nephrol cell proliferation are still controversial. Introduction of TGF-␤ gene into the rat glomerular mesangium was re-11:534A, 2000), which is the downstream of Rho, an another TGF-␤ signaling pathway [17, 18] . Also, angioported to induce not only ECM deposition, but also modest mitogenesis of resident cells [28] . These findings tensin-converting enzyme (ACE) inhibitors and angiotensin II type I receptor (AT1) antagonists, which have might explain that blocking for TGF-␤IIR reduced the total number of glomerular cells at day 7. Further studies already been clinically used, are known to be renoprotective agents by reducing TGF-␤ expression as well as are needed to determine the in vivo effects of TGF-␤ on the glomerular cell proliferation. decrease of intraglomerular capillary pressure [19] [20] [21] . Dietary protein restriction reduces TGF-␤ expression as
Transforming growth factor-␤ was reported to have an anti-inflammatory function [9, 29] . In our study, the well [22] . However, there have been no reports demonstrating that blocking of TGF-␤ receptor function prenumber of macrophages in early phase was not different between group I and group II. Therefore, we thought that vents renal fibrosis. Our studies showed for the first time that direct inhibition of TGF-␤IIR is effective to prevent JMAb-45 did not influence on macrophage infiltration at early time point of this experiment. However, macro-ECM deposition using rat anti-Thy-1 nephritis.
The present work tested the effects of a fully human phage infiltration was significantly inhibited at day 7. While the difference was small (group I, 3.4 Ϯ 0.3 macrophages/ monoclonal antibody against TGF-␤IIR in a rat antiThy-1 nephritis. First, we studied expression of TGF-␤IIR glomerulus; group II, 4.8Ϯ1.2 macrophages/glomerulus), we cannot ignore the possibility that JMAb-45 might in the kidneys from normal rats and anti-Thy-1 nephritis rats at day 7. In the normal condition, TGF-␤IIR is influence macrophage infiltration. More investigations are required to define this question. strongly expressed in glomerular visceral epithelial cells and weakly in the apical site of tubular epithelial cells.
Urinary protein excretion was significantly decreased in group I compared with group II. In other studies the Recently, TGF-␤ 2 and 3 have been shown to be expressed in glomerular visceral epithelial cells as well as decrease of urinary protein excretion was indicated in anti-Thy-1 nephritis animals treated with decorin admin-TGF-␤IIR [16, 23] . Interaction of TGF-␤ and TGF-␤IIR may contribute to maintain the structure and function istration or with decorin gene therapy [6, 7] , which attenuated TGF-␤. Heparan sulfate proteoglycans (HSPG) are of glomerular capillary wall in normal rat glomerulus. Administration of 1-22-3 monoclonal antibody to rats components of glomerular basement membrane (GBM), and HSPG alterations may contribute to the GBM's perleads to proliferative glomerulonephritis [15] , which is characterized by complement-dependent injury of mesanmeability. One of the mechanisms leading to a reduced HSPG function is depolymerization by oxygen or nitrogial cells, followed by mesangial proliferation [15, 24, 25] . Then transient ECM deposition is observed. Previous gen radicals [30] . TGF-␤ was reported to increase GBM permeability via reactive oxygen species (ROS) producstudies demonstrated that TGF-␤ was a crucial factor for accumulation of ECM in this model at day 7 [4-8, 16].
tion of glomerular resident cells [31] . It is possible that ROS production might be reduced by anti-TGF-␤IIR anti-TGF-␤ was increased in the mesangial proliferative lesions and peaked at day 7 [16], whereas expression of body treatment. Serum creatinine also was decreased in group I rats. Improvement of glomerular morphological TGF-␤IIR has not been studied yet. As expected, TGF-␤ IIR was dramatically up-regulated in the mesangial proand functional changes by JMAb-45 might contribute to the improved creatinine level. In addition, tubulointerstiliferative lesions, tubular epithelial cells, and interstitial cells of the kidneys from anti-Thy-1 nephritis obtained tial damage ameliorated by anti-TGF-␤IIR antibody injection might have influenced on serum creatinine level [32] . at day 7. In this experiment, rats were divided into three groups to explore the effects of the fully human antiTransforming growth factor-␤ is well known as a major promoter of myofibroblast differentiation. In mesangial TGF-␤IIR monoclonal antibody (JMAb-45). In group I, TGF-␤IIR antibody apparently reduced the deposition cells, TGF-␤ induces ␣-SMA expression (abstract; Imai et al, J Am Soc Nephrol 5:782, 1994) [33] and enhances of fibronectin-EDA and type I collagen. Physiological and histological findings at day 1 and day 3 were not synthesis of ECM including fibronectin-EDA [34] . Anti-EDA monoclonal antibody specifically blocks TGF-␤-different between group I and group II. Therefore, we thought that the injection of JMAb-45 did not influence induced expression of ␣-SMA but not that of plasminogen activator inhibitor-1 [35] . In anti-Thy-1 nephritis at on the early phase of this model, and believed that the difference in ECM deposition at day 7 was dependent day 7, JMAb-45 reduced ␣-SMA expression as well as 
